The global non-vascular stents market is expected to grow from US$ 970.6 million in 2022 to US$ 1,326.3 million by 2028, at a CAGR of 5.5%. Non-vascular stents are medical devices used to treat blockages or narrowed passages in various parts of the body, such as the gastrointestinal tract, respiratory tract, and urinary tract. They are made of various materials, such as metal, plastic, and silicone, and are available in a variety of shapes and sizes.

Non-vascular stents are medical devices that are used to treat a variety of non-vascular conditions. They are typically made of metal or plastic and are inserted into the body through a minimally invasive procedure. Non-vascular stents can be used to open up blocked passageways, support weakened structures, or deliver drugs to specific areas of the body.

Get Your Report Sample to Gain Comprehensive Insights! https://bit.ly/3MKbIgD

Market Drivers:

The growth of the non-vascular stents market is being driven by a number of factors, including:

  • The increasing prevalence of chronic diseases such as cancer, heart disease, and diabetes, which can lead to blockages in various parts of the body.
  • The rising demand for minimally invasive procedures to treat these diseases.
  • The technological advancements in non-vascular stents, such as the development of drug-eluting stents and biodegradable stents.
  • The increasing awareness of non-vascular stents among patients and physicians.

Key Takeaways:

  • The global non-vascular stents market is expected to grow from US$ 970.6 million in 2022 to US$ 1,326.3 million by 2028, at a CAGR of 5.5%.
  • The growth of the market is attributed to factors such as the increasing prevalence of chronic diseases, the rising demand for minimally invasive procedures, and the growing awareness of non-vascular stents.
  • The esophageal stent segment is expected to account for the largest share of the market during the forecast period. This is due to the high prevalence of esophageal cancer and the increasing use of esophageal stents for the treatment of this condition.
  • The North American region is expected to dominate the market during the forecast period. This is due to the high prevalence of chronic diseases and the well-established healthcare system in the region.

Regional Analysis:

North America is the largest market for non-vascular stents, followed by Europe and Asia Pacific. The growth of the North American market is being driven by the high prevalence of chronic diseases and the rising demand for minimally invasive procedures. The growth of the European market is being driven by the increasing awareness of non-vascular stents and the technological advancements in this field. The growth of the Asia Pacific market is being driven by the rising disposable incomes and the increasing demand for healthcare services.

Key Players:

  • Boston Scientific
  • COOK MEDICAL
  • ELLA - CS, s.r.o.
  • OLYMPUS
  • B. BRAUN
  • MEDtronic
  • Merit Medical Systems, Inc.
  • H.C.W. Inc.
  • Biotronik AG
  • Taewoong Medical Co., Ltd.
  • ABIOMED, Inc.

Segmentation:

By Product Type:

  • Esophageal Stents
  • Biliary Stents
  • Ureteric Stents
  • Duodenal Stents
  • Tracheal Stents
  • Others

By Application:

  • Benign Diseases
  • Malignant Diseases
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa